Literature DB >> 18420998

CD44 expressed on both bone marrow-derived and non-bone marrow-derived cells promotes atherogenesis in ApoE-deficient mice.

Liang Zhao1, Eric Lee, Alicia M Zukas, Melissa K Middleton, Michelle Kinder, Pinak S Acharya, Jason A Hall, Daniel J Rader, Ellen Puré.   

Abstract

OBJECTIVE: The purpose of this study was to distinguish the contributions of CD44 expressed on bone marrow-derived and non-bone marrow-derived cells to atherosclerosis. METHODS AND
RESULTS: Using bone marrow chimeras, we compared the contributions of CD44 expressed on bone marrow-derived cells versus non-bone marrow-derived cells to the vascular inflammation underlying atherosclerosis. We show that CD44 in both bone marrow-derived and non-bone marrow-derived compartments promotes atherosclerosis in apoE-/- mice and mediates macrophage and T cell recruitment to lesions in vivo. We also demonstrate that CD44 on endothelial cells (ECs) as well as on macrophages and T cells enhances leukocyte-endothelial cell adhesion and transendothelial migration in vitro. Furthermore, CD44 on vascular smooth muscle cells (VSMCs) regulates their hyaluronan (HA)-dependent migration. Interestingly, in mice lacking CD44 in both compartments, where we observed the least inflammation, we also observed enhanced fibrous cap formation.
CONCLUSIONS: CD44 expressed on bone marrow-derived and non-bone marrow-derived cells both promote atherosclerosis in apoE-deficient mice. Furthermore, CD44 plays a pivotal role in determining the balance between inflammation and fibrosis in atherosclerotic lesions which can impact clinical outcome in humans.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18420998     DOI: 10.1161/ATVBAHA.108.165753

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  20 in total

Review 1.  The CD44-HA axis and inflammation in atherosclerosis: A temporal perspective.

Authors:  Mia Krolikoski; James Monslow; Ellen Puré
Journal:  Matrix Biol       Date:  2018-05-21       Impact factor: 11.583

2.  Identification of a systemic lupus erythematosus susceptibility locus at 11p13 between PDHX and CD44 in a multiethnic study.

Authors:  Christopher J Lessard; Indra Adrianto; Jennifer A Kelly; Kenneth M Kaufman; Kiely M Grundahl; Adam Adler; Adrienne H Williams; Caroline J Gallant; Juan-Manuel Anaya; Sang-Cheol Bae; Susan A Boackle; Elizabeth E Brown; Deh-Ming Chang; Lindsey A Criswell; Jeffrey C Edberg; Barry I Freedman; Peter K Gregersen; Gary S Gilkeson; Chaim O Jacob; Judith A James; Diane L Kamen; Robert P Kimberly; Javier Martin; Joan T Merrill; Timothy B Niewold; So-Yeon Park; Michelle A Petri; Bernardo A Pons-Estel; Rosalind Ramsey-Goldman; John D Reveille; Yeong Wook Song; Anne M Stevens; Betty P Tsao; Luis M Vila; Timothy J Vyse; Chack-Yung Yu; Joel M Guthridge; Gail R Bruner; Carl D Langefeld; Courtney Montgomery; John B Harley; R Hal Scofield; Patrick M Gaffney; Kathy L Moser
Journal:  Am J Hum Genet       Date:  2010-12-30       Impact factor: 11.025

3.  Effective atherosclerotic plaque inflammation inhibition with targeted drug delivery by hyaluronan conjugated atorvastatin nanoparticles.

Authors:  Seyedmehdi Hossaini Nasr; Zahra Rashidijahanabad; Sherif Ramadan; Nate Kauffman; Narayanan Parameswaran; Kurt R Zinn; Chunqi Qian; Ripla Arora; Dalen Agnew; Xuefei Huang
Journal:  Nanoscale       Date:  2020-05-07       Impact factor: 7.790

4.  Effect of serum amyloid A1 treatment on global gene expression in THP-1-derived macrophages.

Authors:  Koon-Yeow Leow; Wilson Wen Bin Goh; Chew-Kiat Heng
Journal:  Inflamm Res       Date:  2012-01-08       Impact factor: 4.575

5.  Effects of Nanoprobe Morphology on Cellular Binding and Inflammatory Responses: Hyaluronan-Conjugated Magnetic Nanoworms for Magnetic Resonance Imaging of Atherosclerotic Plaques.

Authors:  Seyedmehdi Hossaini Nasr; Anne Tonson; Mohammad H El-Dakdouki; David C Zhu; Dalen Agnew; Robert Wiseman; Chunqi Qian; Xuefei Huang
Journal:  ACS Appl Mater Interfaces       Date:  2018-03-27       Impact factor: 9.229

6.  CD44 targeting magnetic glyconanoparticles for atherosclerotic plaque imaging.

Authors:  Mohammad H El-Dakdouki; Kheireddine El-Boubbou; Medha Kamat; Ruiping Huang; George S Abela; Matti Kiupel; David C Zhu; Xuefei Huang
Journal:  Pharm Res       Date:  2013-04-09       Impact factor: 4.200

Review 7.  Hyaluronan as a therapeutic target in human diseases.

Authors:  Jiurong Liang; Dianhua Jiang; Paul W Noble
Journal:  Adv Drug Deliv Rev       Date:  2015-11-02       Impact factor: 15.470

Review 8.  CD44-dependent inflammation, fibrogenesis, and collagenolysis regulates extracellular matrix remodeling and tensile strength during cutaneous wound healing.

Authors:  Priya Govindaraju; Leslie Todd; Snehal Shetye; James Monslow; Ellen Puré
Journal:  Matrix Biol       Date:  2018-06-09       Impact factor: 11.583

9.  Fibroblast Activation Protein Regulates Lesion Burden and the Fibroinflammatory Response in Apoe-Deficient Mice in a Sexually Dimorphic Manner.

Authors:  James Monslow; Leslie Todd; John E Chojnowski; Priya K Govindaraju; Richard K Assoian; Ellen Puré
Journal:  Am J Pathol       Date:  2020-02-19       Impact factor: 4.307

10.  Deletion of Hyaluronan Synthase 3 Inhibits Neointimal Hyperplasia in Mice.

Authors:  Maria Grandoch; Jens W Fischer; Lena S Kiene; Susanne Homann; Tatsiana Suvorava; Berit Rabausch; Julia Müller; Georg Kojda; Inga Kretschmer; Sören Twarock; Guang Dai; René Deenen; Sonja Hartwig; Stefan Lehr; Karl Köhrer; Rashmin C Savani
Journal:  Arterioscler Thromb Vasc Biol       Date:  2015-11-19       Impact factor: 8.311

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.